Healthcare
StarHub unveils LifeHub+ platform
StarHub unveils LifeHub+ platform
This will provide consumers access to health and wellness services.
Singapore Food Agency proposes updated guidelines on infant nutrition
Such amendments may result in heightened compliance demands and additional costs for businesses.
Cordlife Group Limited approves potential acquisition by NJXJK
NJXJK is currently reviewing its stake at Cordlife Group with SAC Capital.
MOH updates TB clinical guidelines for 2024
Singapore saw a decrease in new TB cases in 2023 compared to 2022.
CAD arrests Cordlife ex-group chief and four director over alleged breaches of disclosure obligations
The investigation stemmed from potential breaches of disclosure obligations concerning irregular temperatures in a cryogenic storage tank
Cordlife Group Limited requests lift of trading halt
The statement was published at 1:08 a.m.
Cordlife receives requisition notice to hold EGM
Cordlife said that it is considering the requisition notices and is seeking legal advice.
MOH to boost palliative care capacity to 3,600 by 2025
This translates to an increase in capacity by 50%.
BioNTech joins Biologics Pharma Innovation Programme Singapore consortium
The consortium aims to grow Singapore’s capabilities in biologics manufacturing.
MOH to review healthcare financing schemes
MOH will expand the MediShield Life coverage and provide more subsidies to community hospitals.
Aspen announces board changes
The new appointees started their posts on 8 March 2024.
Synapxe, A*STAR partner for health tech innovation in Singapore
The agencies will develop a pilot project to onboard APOLLO onto AimSG.
Singapore's HealthTech agency Synapxe and the Agency for Science, Technology...
Health leaders unveil 3-Step plan to combat cardiovascular disease crisis
Heart disease and strokes account for almost one-third of deaths in SG.
Feedback on amended Regulation 23 of Therapeutic Products regulations sought
Public consultation will run from 1 March to 31 March.
IHH Healthcare declares second dividend on the back of 91% YoY higher PATMI
PATMI for FY23 was RM3.0b ($849m).
SG, Korea signs MRA on medicinal products regulation
The agreement will facilitate trade and access to medicinal products between both countries.
MOH lists abrocitinib on the medical assistance fund
The drug is used to treat atopic dermatitis.
Read Here
Advertise
Sign Up
Commentary
Singapore’s digital confidence in the new retail era